NCT05988645 Performance and Safety of MiWEndo-assisted Colonoscopy (MiWEndo II)
| NCT ID | NCT05988645 |
| Status | Recruiting |
| Phase | — |
| Sponsor | MiWEndo Solutions S.L. |
| Condition | Colorectal Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2023-08-01 |
| Primary Completion | 2025-12-29 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2023-08-01 with a primary completion date of 2025-12-29.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The study involves the planned use of a new microwave-based device during colonoscopy procedures in 50 patients to assess the performance and safety of its use for detection of colorectal polyps and lack of normal clinical practice modification. The device is a final design version, which has been previously tested in several preclinical studies (including phantom studies, an ex vivo study with human tissues, and an in vivo study with porcine model) and in a pilot study in humans (NCT05477836)
Eligibility Criteria
Inclusion Criteria: \- Patients with a previously detected polyp in the rectum referred for resection. These criteria will ensure the probability of finding polyps during the explorations. All the patients will give written informed consent. Exclusion Criteria: * Patients at a high risk of having major complications as perforation or hemorrhage, suspected or proven lower gastrointestinal bleeding, non-correctable coagulopathy or anticoagulant/clopidogrel therapy during procedure, inadequate bowel cleansing. * ASA-IV patients. * Urgent colonoscopy.
Frequently Asked Questions
Who can join the NCT05988645 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Colorectal Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05988645 currently recruiting?
Yes, NCT05988645 is actively recruiting participants. Visit ClinicalTrials.gov or contact MiWEndo Solutions S.L. to inquire about joining.
Where is the NCT05988645 trial being conducted?
This trial is being conducted at Barcelona, Spain.
Who is sponsoring the NCT05988645 clinical trial?
NCT05988645 is sponsored by MiWEndo Solutions S.L.. The trial plans to enroll 50 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.